NMO Clinic

How to get referred to the NMO Program:

If you or a family member has been diagnosed with NMO, or if your healthcare provider suspects you or a family member may have symptoms of NMO, then have your family doctor, ophthalmologist or neurologist complete a referral form and fax it to the NMO Clinic and Research Program. As this is a specialized program, we cannot accept self-referrals for clinical care.

Referrals should be sent by fax to 604-297-9685.

What will happen at the appointment:

  • The first appointment with the NMO Clinic and Research Program may take the whole day. It will involve seeing the Neurologist and possibly all or some of the following staff: nurse, neuro-ophthamologist, and genetic counselor.
  • Previous investigations/results and symptoms will be reviewed and further tests may then be ordered to confirm an NMO diagnosis or to rule out other conditions. Possible tests may include: blood test for antibody aquaporin-4 (AQP4), magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), optical coherence tomography (OCT).
  • Treatment options and recommendations will also be discussed, and a follow-up appointment will be scheduled to review results of any newly ordered tests.
  • Annual visits (or more frequently depending on the clinical judgment of the team) will be planned.

NMO Clinic physicians

Dr. Anthony Traboulsee

Anthony Traboulsee is a Professor and Research Chair of the MS Society of Canada at the University of British Columbia. He is the Medical Director of the MS Clinic, Director of the MS/MRI Research Group, and Director of the MS Clinical Trials Research Group at the University of British Columbia Hospital. He received his B.Sc. from McGill University in Montreal, Canada and his M.D. from Dalhousie University in Halifax, Nova Scotia. He completed a residency in Neurology and fellowship in Multiple Sclerosis at the University of British Columbia Hospital in Vancouver and University College London (Queen Square). His research focus is on the development of practice guidelines for routine use of MRI in the management of MS, establishing advanced MRI imaging outcomes in Multiple Sclerosis, and the treatment of Neuromyelitis Optica.
Dr. Robert Carruthers

Originally from Vancouver, Dr. Carruthers studied medicine at the Tulane University School of Medicine. He did his internshiup at Massachusetts General Hospital, followed by neurology residency at the combined Brigham and Women’s Hospital/Massachusetts General Hospital program. He then undertook a fellowship in Multiple Sclerosis at the Partners MS Center at Brigham and Women’s Hospital. His interests include improving patient care and safety in MS, Neuromyelitis Optica and neuroimmunology.